Citation 103993

KAPADIA,GJ: TOKUDA,H: KONOSHIMA,T: TAKASAKI,M: TAKAYSAU,J: NISHINO,H:. (1996). ANTI-TUMOR PROMOTING ACTIVITY OF DRYOPTERIS PHLOROPHENONE DERIVATIVES.. 105(2)

Citation Details

TitleANTI-TUMOR PROMOTING ACTIVITY OF DRYOPTERIS PHLOROPHENONE DERIVATIVES.
AuthorsKAPADIA,GJ: TOKUDA,H: KONOSHIMA,T: TAKASAKI,M: TAKAYSAU,J: NISHINO,H:
Year1996
Volume105
Issue2

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASPIDINOL B
WEAK ACTIVITY
2
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILICINIC ACID,BUTYRYL:
EQUIVOCAL
3
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLOROGLUCINOL,BUTYRYL-3-METHYL:
EQUIVOCAL
4
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLOROGLUCINOL,BUTYRYL:
EQUIVOCAL
5
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DEASPIDINOL
WEAK ACTIVITY
6
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILICINIC ACID,DIBUTYRYL:
STRONG ACTIVITY
7
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLOROGLUCINOL,DIBUTYRYL:
ACTIVE
8
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILICINIC ACID
WEAK ACTIVITY
9
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASPIDINOL,ISO:
WEAK ACTIVITY
10
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DEASPIDINOL,ORTHO:
INACTIVE
11
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ALBASPIDIN AA
WEAK ACTIVITY
12
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ALBASPIDIN BB
WEAK ACTIVITY
13
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASPIDIN
STRONG ACTIVITY
14
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASPIDIN,PSEUDO:
WEAK ACTIVITY
15
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DEASPIDIN
STRONG ACTIVITY
16
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLOROPYRONE,DEBUTYRYL:
WEAK ACTIVITY
17
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FLAVASPIDIC ACID AB
WEAK ACTIVITY
18
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FLAVASPIDIC ACID BB
WEAK ACTIVITY
19
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FLAVASPIDIC ACID PB
WEAK ACTIVITY
20
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MARGASPIDIN AB
ACTIVE
21
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MARGASPIDIN BB
ACTIVE
22
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASPIDINOL BB,METHYLENE-BIS:
ACTIVE
23
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASPIDIN AB,PARA:
WEAK ACTIVITY
24
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLORASPIDIN
STRONG ACTIVITY
25
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASPIDIN BB,PARA:
WEAK ACTIVITY
26
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLORASPIDINOL BB
WEAK ACTIVITY
27
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHLOROPYRONE
WEAK ACTIVITY
28
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILIXIC ACID ABA
WEAK ACTIVITY
29
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILIXIC ACID ABB
WEAK ACTIVITY
30
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILIXIC ACID BBB
STRONG ACTIVITY
31
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILIXIC ACID PBB
ACTIVE
32
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FILIXIC ACID PBP
ACTIVE
33
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DRYOCRASSIN
ACTIVE
Show SPARQL Queries (1)